Article
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
Cell - 27 Jun 2008
Dreses-Werringloer Ute, Lambert Jean-Charles, Vingtdeux Valérie, Zhao Haitian, Vais Horia, Siebert Adam, Jain Ankit, Koppel Jeremy, Rovelet-Lecrux Anne, Hannequin Didier, Pasquier Florence, Galimberti Daniela, Scarpini Elio, Mann David, Lendon Corinne, Campion Dominique, Amouyel Philippe, Davies Peter, Foskett J Kevin, Campagne Fabien, Marambaud Philippe
Abstract excerpt
Alzheimer's disease (AD) is a genetically heterogeneous disorder characterized by early hippocampal atrophy and cerebral amyloid-beta (Abeta) peptide deposition. Using TissueInfo to screen for genes preferentially expressed in the hippocampus and located in AD linkage regions, we identified a gene on 10q24.33 that we call CALHM1. We show that CALHM1 encodes a multipass transmembrane glycoprotein that controls...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
